abu-abeeleh, Jaafar, et al. “SIMVASTATIN TREATMENT AMELIORATES DIABETIC TYPE 2 CONDITIONS THROUGH LOWERING THE CONCENTRATION OF PLASMA ICAM LEVELS”. European Scientific Journal, ESJ, vol. 11, no. 24, Aug. 2015, https://last.eujournal.org/index.php/esj/article/view/6096.